Large-scale preparation of amorphous cefixime nanoparticles by antisolvent precipitation in a high-gravity rotating packed bed

Industrial and Engineering Chemistry Research

Volumn 54, Issue 33, 2015, Pages 8157-8165

  Kuang, Yun Yun ^a,b   Zhang, Zhi Bing ^b   Xie, Miao Ling ^b   Wang, Jie Xin ^a   Le, Yuan ^a   Chen, Jian Feng ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b Research Center of the Ministry of Education for High Gravity Engineering and Technology Beijing University of Chemical Technology ^*  (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; DISSOLUTION; NANOPARTICLES; PACKED BEDS; PARTICLE SIZE; SOLUBILITY; SUPERSATURATION;

ANTI-SOLVENT PRECIPITATIONS; CONTINUOUS OPERATION; LARGE SCALE PREPARATION; OPERATING VARIABLES; ORAL BIOAVAILABILITIES; PRODUCTION CAPACITY; ROTATING PACKED BED; SATURATION SOLUBILITY;

PRECIPITATION (CHEMICAL);

EID: 84940523290     PISSN: 08885885     EISSN: 15205045     Source Type: Journal    
DOI: 10.1021/acs.iecr.5b01584     Document Type: Article

References (37)

1. Matteucci, M. E.; Brettmann, B. K.; Rogers, T. L.; Elder, E. J.; Williams, R. O., III; Johnston, K. P. Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media. Mol. Pharmaceutics 2007, 4, 782-793.
2. Matteucci, M. E.; Miller, M. A.; Williams, R. O., III; Johnston, K. P. Highly supersaturated solutions of amorphous drugs approaching predictions from configurational thermodynamic properties. J. Phys. Chem. B 2008, 112, 16675-16681.
3. Hancock, B. C.; Parks, M. What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 2000, 17, 397-404.
4. Miller, M. A.; DiNunzio, J.; Matteucci, M. E.; Ludher, B. S.; Williams, R. O.; Johnston, K. P. Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability. Drug Dev. Ind. Pharm. 2012, 38, 557-570.
5. Raghavan, S. L.; Kiepfer, B.; Davis, A. F.; Kazarian, S. G.; Hadgraft, J. Membrane transport of hydrocortisone acetate from supersaturated solutions: the role of polymers. Int. J. Pharm. 2001, 221, 95-105.
6. Kumprakob, U.; Kawakami, J.; Adachi, I. Permeation enhancement of ketoprofen using a supersaturated system with antinucleant polymers. Biol. Pharm. Bull. 2005, 28, 1684-1688.
7. Matteucci, M. E.; Paguio, J. C.; Miller, M. A.; Williams, R. O., III; Johnston, K. P. Flocculated amorphous nanoparticles for highly supersaturated solutions. Pharm. Res. 2008, 25, 2477-2487.
8. Alonzo, D. E.; Zhang, G. G.; Zhou, D.; Gao, Y.; Taylor, L. S. Understanding the behavior of amorphous pharmaceutical systems during dissolution. Pharm. Res. 2010, 27, 608-618.
9. Zhang, Q. X.; Xu, L. M.; Zhou, Y.; Wang, J. X.; Chen, J. F. Preparation of drug nanoparticles using a T-junction microchannel system. Ind. Eng. Chem. Res. 2011, 50, 13805-13812.
10. Teng, W.; Wang, J. X.; Foster, N. R.; Wen, N.; Zhang, J. J. Preparation of silybin/poly(vinylpyrrolidone) nanodrugs by using the aerosol solvent extraction system for improving drug solubility. Ind. Eng. Chem. Res. 2014, 53, 10519-10524.
11. Hou, C. D.; Wang, J. X.; Le, Y.; Zou, H. K.; Zhao, H. Preparation of azithromycin nanosuspensions by reactive precipitation method. Drug Dev. Ind. Pharm. 2012, 38, 848-854.
12. Chen, X. X.; Young, T. J.; Sarkari, M.; Williams, R. O., III; Johnston, K. P. Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution. Int. J. Pharm. 2002, 242, 3-14.
13. Mou, D. S.; Chen, H. B.; Wan, J. L.; Xu, H. B.; Yang, X. L. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. Int. J. Pharm. 2011, 413, 237-244.
14. Dhumal, R. S.; Biradar, S. V.; Yamamura, S.; Paradkar, A. R.; York, P. Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability. Eur. J. Pharm. Biopharm. 2008, 70, 109-115.
15. Zhao, H.; Wang, J. X.; Zhang, H. X.; Shen, Z. G.; Yun, J.; Chen, J. F. Facile preparation of danazol nanoparticles by high-gravity antisolvent precipitation (HGAP) method. Chin. J. Chem. Eng. 2009, 17, 318-323.
16. Castro, F.; Kuhn, S.; Jensen, K.; Ferreira, A.; Rocha, F.; Vicente, A.; Teixeira, J. A. Process intensification and optimization for hydroxyapatite nanoparticles production. Chem. Eng. Sci. 2013, 100, 352-359.
17. Rao, D. P.; Bhowal, A.; Goswami, P. S. Process intensification in rotating packed beds (higee): an appraisal. Ind. Eng. Chem. Res. 2004, 43, 1150-1162.
18. Rahimi, M.; Valeh-e-Sheyda, P.; Parsamoghadam, M. A.; Azimi, N.; Abidi, H. LASP and Villermaux/Dushman protocols for mixing performance in microchannels: Effect of geometry on micromixing characterization and size reduction. Chem. Eng. Process. 2014, 85, 178-186.
19. Chen, J. F.; Wang, Y. H.; Guo, F.; Wang, X. M.; Zheng, C. Synthesis of nanoparticles with novel technology: high gravity reactive precipitation. Ind. Eng. Chem. Res. 2000, 39, 948-954.
20. Hessel, V.; Lowe, H.; Schonfeld, F. Micromixers-A review on passive and active mixing principles. Chem. Eng. Sci. 2005, 60, 2479-2501.
21. Chen, J. F.; Shao, L. Mass production of nanoparticles by high gravity reactive precipitation technology with low cost. China Particuol. 2003, 1, 64-69.
22. Chen, J. F.; Zhou, M. Y.; Shao, L.; Wang, Y. Y.; Yun, J.; Chew, N. Y.; Chan, H. K. Feasibility of preparing nanodrugs by high-gravity reactive precipitation. Int. J. Pharm. 2004, 269, 267-274.
23. Chiou, H.; Li, L.; Hu, T. T.; Chan, H. K.; Chen, J. F.; Yun, J. Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation. Int. J. Pharm. 2007, 331, 93-98.
24. Chen, J. F.; Zhang, J. Y.; Shen, Z. G.; Zhong, J.; Yun, J. Preparation and characterization of amorphous cefuroxime axetil drug nanoparticles with novel technology: high-gravity antisolvent precipitation. Ind. Eng. Chem. Res. 2006, 45, 8723-8727.
25. Zhang, Z. L.; Le, Y.; Wang, J. X.; Zhao, H.; Chen, J. F. Development of stabilized itraconazole nanodispersions by using high-gravity technique. Drug Dev. Ind. Pharm. 2012, 38, 1512-1520.
26. Yu, L.; Li, C. X.; Le, Y.; Chen, J. F.; Zou, H. K. Stabilized amorphous glibenclamide nanoparticles by high-gravity technique. Mater. Chem. Phys. 2011, 130, 361-366.
27. Zhang, T. W.; Liu, Q.; Xie, Z. P.; Song, X. P.; Gong, J. B. Determination and correlation of solubility data and dissolution thermodynamic data of cefixime trihydrate in seven pure solvents. J. Chem. Eng. Data 2014, 59, 1915-1921.
28. Khamda, M.; Hosseini, M. H.; Rezaee, M. Measurement and correlation solubility of cefixime trihydrate and oxymetholone in supercritical carbon dioxide (CO2). J. Supercrit. Fluids 2013, 73, 130-137.
29. Varia, U.; Patil, C.; Kalyane, N.; Agrawal, P. Effect of cyclodextrin inclusion complex on dissolution behaviour of cefixime. J. Pharm. Res. 2010, 3, 570-574.
30. Saindane, D. S.; Kulkarni, A. S.; Sagri, A. N.; Khade, T. S.; Patil, M. D. Dissolution improvement of poorly water soluble drug by freeze drying with PVP K-30. Int. J. Pharm. Technol. 2010, 1, 149-162.
31. Jadhav, P.; Petkar, B.; Pore, Y.; Kulkarni, A.; Burade, K. Physicochemical and molecular modeling studies of cefixime-Larginine-cyclodextrin ternary inclusion compounds. Carbohydr. Polym. 2013, 98, 1317-1325.
32. Galisteo-González, F.; Molina-Bolívar, J. A. Systematic study on the preparation of BSA nanoparticles. Colloids Surf., B 2014, 123, 286-292.
33. Horn, D.; Rieger, J. Organic nanoparticles in the aqueous phasetheory, experiment, and use. Angew. Chem., Int. Ed. 2001, 40, 4330-4361.
34. Zhang, H.; Wang, D.; Butler, R.; Campbell, N. L.; Long, J.; Tan, B.; Duncalf, D. J.; Foster, A. J.; Hopkinson, A.; Taylor, D.; Angus, D.; Cooper, A. I.; Rannard, S. P. Formation and enhanced biocidal activity of water-dispersable organic nanoparticles. Nat. Nanotechnol. 2008, 3, 506-511.
35. Lindfors, L.; Skantze, P.; Skantze, U.; Rasmusson, M.; Zackrisson, A.; Olsson, U. Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening. Langmuir 2006, 22, 906-910.
36. Gao, L.; Zhang, D.; Chen, M.; Zheng, T.; Wang, S. Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement. Drug Dev. Ind. Pharm. 2007, 33, 1332-1339.
37. Tolman, J. A.; Williams, R. O., III Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties. Drug Dev. Ind. Pharm. 2010, 36, 1-30.